BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 21320258)

  • 1. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Acta Psychiatr Scand; 2010 Sep; 122(3):246-54. PubMed ID: 20136801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.
    Schaffer A; Zuker P; Levitt A
    J Affect Disord; 2006 Nov; 96(1-2):95-9. PubMed ID: 16820213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
    Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
    Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
    Chang JS; Moon E; Cha B; Ha K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.
    Kessing LV; Hellmund G; Andersen PK
    J Psychopharmacol; 2012 May; 26(5):644-52. PubMed ID: 21948935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
    Redmond JR; Jamison KL; Bowden CL
    CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).
    Carlson BX; Ketter TA; Sun W; Timko K; McQuade RD; Sanchez R; Vester-Blokland E; Marcus R
    Bipolar Disord; 2012 Feb; 14(1):41-53. PubMed ID: 22329471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.
    Sagud M; Pivac N; Mustapic M; Nedic G; Peles AM; Kramaric M; Jakovljevic M; Muck-Seler D
    Psychopharmacology (Berl); 2008 May; 197(4):683-5. PubMed ID: 18246328
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar rapid cycling: focus on depression as its hallmark.
    Calabrese JR; Shelton MD; Bowden CL; Rapport DJ; Suppes T; Shirley ER; Kimmel SE; Caban SJ
    J Clin Psychiatry; 2001; 62 Suppl 14():34-41. PubMed ID: 11469674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.